Bosh sahifa068270 • KRX
add
Celltrion Inc
Yopilish kursi
173 700,00 ₩
Kunlik diapazon
173 000,00 ₩ - 176 500,00 ₩
Yillik diapazon
157 500,00 ₩ - 241 000,00 ₩
Bozor kapitalizatsiyasi
37,66 trln KRW
Oʻrtacha hajm
548,33 ming
Narx/foyda
191,13
Dividend daromadliligi
0,29%
Bozor yangiliklari
MarketWatch
1 kun oldin
S&P 500 is on a 12-month tear as tariffs threaten 2025 outlook for U.S.
stocks
1,12%
0,35%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 881,93 mlrd | 31,18% |
Joriy xarajat | 255,73 mlrd | 148,90% |
Sof foyda | 85,59 mlrd | -61,41% |
Sof foyda marjasi | 9,71 | -70,58% |
Har bir ulushga tushum | 414,00 | -73,48% |
EBITDA | 283,35 mlrd | -13,69% |
Amaldagi soliq stavkasi | 52,82% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,18 trln | 190,82% |
Jami aktivlari | 20,31 trln | 209,79% |
Jami passivlari | 3,28 trln | 57,87% |
Umumiy kapital | 17,03 trln | — |
Tarqatilgan aksiyalar | 206,09 mln | — |
Narxi/balansdagi bahosi | 2,12 | — |
Aktivlardan daromad | 2,57% | — |
Kapitaldan daromad | 2,70% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 85,59 mlrd | -61,41% |
Operatsiyalardan naqd pul | 265,31 mlrd | 653,96% |
Sarmoyadan naqd pul | -136,41 mlrd | -38,41% |
Moliyadan naqd pul | -47,95 mlrd | 61,66% |
Naqd pulning sof oʻzgarishi | 68,24 mlrd | 125,70% |
Boʻsh pul | 265,58 mlrd | 234,44% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
1 074
